摘要 |
The present inventions relate to a (1S,5R,6S)- or (1SR,5RS,6SR)-3-fluoro-2-oxobicyclo[3.1.0]hex-3-ene-6--carboxylic acid derivative represented by Formula (1): (see formula 1) [in the formula, R represents OR1 or NR1R2, wherein R1 and R2 are identical or different, and each represents a hydrogen atom, a C1-C6 alkyl group, a C3-C6 cycloalkyl group, a(C3-C6 cycloalkyl) (C1-C6 alkyl) group, an aryl group, an aryl (C1-C6 alkyl) group, a (C1-C6 alkoxy) (C1-C6 alkyl) group, a C1-C6 hydroxyalkyl group, a (C1-C6 alkylthio) (C1-C6 alkyl) group, or a C1-C6 mercaptoalkyl group], and a process for producing the same, and a process for efficiently producing a fluorine-containing amino acid compound acting on group 2 metabotropic glutamate receptors, which has treatment effects or prevention effects on psychiatric diseases or neurological diseases, characterized by hydrogenating the derivative, and subsequently, subjecting it to hydantoination or aminocyanidation, followed by hydrolysis.
|
申请人 |
TAISHO PHARMACEUTICAL CO., LTD. |
发明人 |
TAGUCHI, TAKEO;KUMAGAI, TOSHIHITO;SAKAGAMI, KAZUNARI;ITO, HISANAKA;NAKAZATO, ATSURO;TOMISAWA, KAZUYUKI |